The HIV-encoded aspartyl proteinase (HIV PR) is critical to the life cycle of the AIDS virus. Although an enormous effort has been put into the design of inhibitors of the HIV PR, there is relatively little fundamental knowledge of this important enzyme. It is the goal of this research to carry out basic studies of the HIV PR molecule, and to understand how the properties of this enzyme originate in its chemical structure, both covalent and folded/three dimensional. The long-term aims of this research are to provide a detailed understanding of the molecular principles by which the HIV PR recognizes its substrates and catalyzes their specific hydrolysis. Such understanding of how the HIV PR works will contribute to the design and evaluation of more effective enzyme inhibitors as potential AIDS therapeutics. The specific studies envisioned in this proposal can be divided into five categories: 1. improved total chemical synthesis of the HIV PR molecule (2 x 99 residue peptide chains; 21.5 kDa); 2. folding (including dimer formation) & thermodynamic stability; 3. substrate recognition; 4. catalysis; 5. redesign of enzyme action. In each of these areas the applicant will use the tools of chemistry to probe in hitherto unprecedented ways the structure-function relationships in HIV PR. The understanding arrived at will be tested by fundamental redesign of the enzyme to work on different substrates, under different conditions, and to use altered molecular structure to carry out new chemical reactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM048897-04
Application #
2331986
Study Section
Special Emphasis Panel (ZRG5-AAR (04))
Project Start
1993-08-01
Project End
1998-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Gryphon Therapeutics
Department
Type
DUNS #
City
South San Francisco
State
CA
Country
United States
Zip Code
94080
Lu, W; Randal, M; Kossiakoff, A et al. (1999) Probing intermolecular backbone H-bonding in serine proteinase-protein inhibitor complexes. Chem Biol 6:419-27
Lu, W; Starovasnik, M A; Kent, S B (1998) Total chemical synthesis of bovine pancreatic trypsin inhibitor by native chemical ligation. FEBS Lett 429:31-5
Lu, W; Qasim, M A; Laskowski Jr, M et al. (1997) Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain. Biochemistry 36:673-9
Muir, T W; Dawson, P E; Kent, S B (1997) Protein synthesis by chemical ligation of unprotected peptides in aqueous solution. Methods Enzymol 289:266-98
Muir, T W; Dawson, P E; Fitzgerald, M C et al. (1996) Probing the chemical basis of binding activity in an SH3 domain by protein signature analysis. Chem Biol 3:817-25
Dawson, P E; Muir, T W; Clark-Lewis, I et al. (1994) Synthesis of proteins by native chemical ligation. Science 266:776-9
Baca, M; Kent, S B (1993) Catalytic contribution of flap-substrate hydrogen bonds in ""HIV-1 protease"" explored by chemical synthesis. Proc Natl Acad Sci U S A 90:11638-42